Outcome of COVID‐19 in patients with chronic myeloid leukemia: A single centre UK experience

Saved in:
Bibliographic Details
Published inJournal of medical virology Vol. 94; no. 4; pp. 1274 - 1276
Main Authors Nesr, George, Saleem, Zahbia, Arami, Siamak
Format Journal Article
LanguageEnglish
Published United States Wiley Subscription Services, Inc 01.04.2022
Subjects
Adult
Aged
Antineoplastic Agents - therapeutic use
Chronic myeloid leukemia
Comorbidity
COVID-19
COVID-19 - complications
COVID-19 - diagnosis
COVID-19 - epidemiology
COVID-19 - therapy
Ethnicity
Female
Humans
Leukemia
Leukemia, Myelogenous, Chronic, BCR-ABL Positive - complications
Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy
Leukemia, Myelogenous, Chronic, BCR-ABL Positive - epidemiology
Male
Middle Aged
Myeloid leukemia
Protein Kinase Inhibitors - therapeutic use
SARS-CoV-2 - isolation & purification
Severity of Illness Index
Treatment Outcome
United Kingdom - epidemiology
Virology
Young Adult
United Kingdom
Online AccessGet full text

Cover

More Information
Bibliography:George Nesr and Zahbia Saleem contributed equally to this study.
SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ISSN:0146-6615
1096-9071
DOI:10.1002/jmv.27527